Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.01 AUD 25% Market Closed
Market Cap: 10.9m AUD

Wall Street
Price Targets

PER Price Targets Summary
Percheron Therapeutics Ltd

There are no price targets for PER.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Percheron Therapeutics Ltd Competitors:
Price Targets
OGI
OrganiGram Holdings Inc
35% Upside
000513
Livzon Pharmaceutical Group Inc
30% Upside
002001
Zhejiang Nhu Co Ltd
27% Upside
VIRP
Virbac SA
21% Upside
128940
Hanmi Pharm Co Ltd
8% Upside
FAE
Faes Farma SA
11% Upside

Revenue
Forecast

Revenue Estimate
Percheron Therapeutics Ltd

For the last 13 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is 11%. The projected CAGR for the next 2 years is 132%.

11%
Past Growth
132%
Estimated Growth
Estimates Accuracy
-81%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Percheron Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PER's stock price target?
Not Available

PER doesn't have any price targets made by Wall Street professionals.

What is Percheron Therapeutics Ltd's Revenue forecast?
Projected CAGR
132%

For the last 13 years the compound annual growth rate for Percheron Therapeutics Ltd's revenue is 11%. The projected CAGR for the next 2 years is 132%.

Back to Top